About Hanh

This author has not yet filled in any details.
So far Hanh has created 174 blog entries.

PRESS RELEASE: IVI Releases Public Comments on Non-Small Cell Lung Cancer Value Tool

Thank you for your comments! IVI has released all public feedback received during the open comment period for the IVI-NSCLC model - our open-source platform to assess therapy sequences for EGFR+ non-small cell lung cancer. In the spirit of IVI's mission of collaboration, commitment to transparency, and dedication to iterative improvement, we look forward to [...]

2019-07-18T13:08:44-06:00July 18th, 2019|IVI News, Press|

5 Steps to Build an Active Learning System for Value Assessment

In the wake of this year's ISPOR conference, IVI's Executive Director, Jennifer Bright, reflects on how to move value assessment from a static snapshot in time to an active learning approach. She discusses the following five steps to improving value assessment: Take the transparency challenge. Embrace flexibility. Allow for iteration. Improve incorporation of non-clinical data. [...]

2019-07-01T16:23:22-06:00July 1st, 2019|IVI News, Viewpoints|

Heard at ISPOR: Wide Ranging Podcast with IVI on Advanced Value Assessment Methods and the QALY Controversy

The IVI team sat down with the Journal of Clinical Pathways while at ISPOR for an in-depth discussion about why advanced value assessment is needed and how it’s progressing. The team also discussed the QALY – what it is and whether it can be improved. To listen to the podcast or read the transcript, click [...]

2019-06-12T12:48:09-06:00June 12th, 2019|IVI News, Press|

IVI Comments on ICER’s 2020 Value Assessment Framework

As part of the public input process, IVI submitted comments on the Institute for Clinical and Economic Review’s (ICER) 2020 Value Assessment Framework. In May, ICER invited public comments as part of their process to update methods that underpin ICER reports. In summary, IVI wrote that value assessment must: • Provide flexible models that can [...]

2019-06-11T18:13:42-06:00June 11th, 2019|IVI News|

The Pros and Cons of the QALY: An AJMC Podcast with Jennifer Bright and Lou Garrison

After the panel presentation, “The Controversial QALY: Is There a Middle Ground in the Debate?” was wrapped up at ISPOR, AJMC deputy editor, Jaime Rosenberg, sat down with IVI's Jennifer Bright and Lou Garrison (assistant director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington) to drill down further into the [...]

2019-06-11T08:29:36-06:00June 10th, 2019|IVI News|

IVI Moderated ISPOR Panel: The Controversial QALY

IVI Executive Director, Jennifer Bright, moderated a fascinating panel discussion on the quality-adjusted life-year (QALY) and whether there is room for a middle ground in the discussion about its merits and shortcomings. Lou Garrison, PhD, Assistant Director of the Pharmaceutical Outcomes Research and Policy Program at the University of Washington; Eleanor M. Perfetto, PhD, MS, [...]

2019-06-07T16:19:01-06:00June 7th, 2019|Events, IVI News|

PRESS RELEASE: IVI Launches New Research Brief Series “Value Blueprints”

IVI launches a new research brief series to present research findings and method insights from the OSVP. Let’s sparks a conversation into next-gen value assessment. Read the full press release here.

2019-10-11T11:44:18-06:00May 20th, 2019|IVI News, Press, Publications, Research|

IVI Announces a Request for Proposal (RFP)

IVI is committed to exploring scientifically rigorous methods that improve the practice of value assessment in a collaborative, iterative environment. To that end, we are pleased to announce the call for research proposals that help us advance our mission and demonstrate the applicability of patient-defined factors of value. IVI welcomes proposals from individual researchers as [...]

2019-07-31T13:22:40-06:00May 16th, 2019|Business Development, IVI News|

IVI’s Jeroen Jensen and Devin Incerti write in the Journal of Managed Care and Specialty Pharmacy

IVI's Lead Scientific Advisor and Lead Economist for the Open-Source Value Platform (OSVP), Jeroen Jansen and Devin Incerti, respectively, collaborate with Jeffery Curtis in a recent article published in the Journal of Managed Care and Specialty Pharmacy about how IVI’s open-source approach to value assessment provides a way to adapt formal assessments of value—long the [...]

2019-05-07T15:04:08-06:00May 7th, 2019|IVI News, Publications|

Jennifer Bright Addresses Differences Between Consumer-Driven and Patient-Centered Healthcare

IVI Executive Director, Jennifer Bright, writes in Morning Consult about the differences between patient-centered and consumer-driven healthcare. Read the full article here.

2019-05-28T16:43:45-06:00May 2nd, 2019|IVI News, Viewpoints|